Baader Bank Aktiengesellschaft’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.5M | Buy |
+14,289
| New | +$7.5M | 0.54% | 40 |
|
|
2025
Q1 | – | Sell |
-866
| Closed | -$617K | – | 435 |
|
|
2024
Q4 | $617K | Sell |
866
-79
| -8% | -$56.3K | 0.04% | 167 |
|
|
2024
Q3 | $992K | Sell |
945
-22
| -2% | -$23.1K | 0.06% | 140 |
|
|
2024
Q2 | $1.01M | Buy |
967
+262
| +37% | +$274K | 0.06% | 139 |
|
|
2024
Q1 | $679K | Sell |
705
-35
| -5% | -$33.7K | 0.05% | 173 |
|
|
2023
Q4 | $648K | Sell |
740
-19
| -3% | -$16.6K | 0.05% | 163 |
|
|
2023
Q3 | $622K | Buy |
759
+29
| +4% | +$23.8K | 0.04% | 157 |
|
|
2023
Q2 | $525K | Sell |
730
-99
| -12% | -$71.1K | 0.03% | 172 |
|
|
2023
Q1 | $678K | Buy |
829
+19
| +2% | +$15.5K | 0.03% | 162 |
|
|
2022
Q4 | $584K | Hold |
810
| – | – | 0.03% | 183 |
|
|
2022
Q3 | $558K | Sell |
810
-240
| -23% | -$165K | 0.04% | 195 |
|
|
2022
Q2 | $621K | Sell |
1,050
-230
| -18% | -$136K | 0.05% | 177 |
|
|
2022
Q1 | $894K | Hold |
1,280
| – | – | 0.07% | 144 |
|
|
2021
Q4 | $808K | Buy |
+1,280
| New | +$808K | 0.06% | 167 |
|